Uncategorized
Takeda ends partnership with Denali amid restructuring
Takeda’s ongoing restructuring has hit another Denali program as an eight-year-old partnership comes to an end between the two companies.
Takeda returned the full rights to a Denali drug called DNL593 ahead of a Phase …